Abstract： Stereotactic body radiation therapy (SBRT) for locally advanced pancreatic cancer (LAPC) shows good signs of efficacy as measured by local control,which can also reduce toxicity. The dose fractionation in foreign countries have changed from conventional fractionation to single fraction and finally moderate hypofractionation. It is similar to that in China,with the dose fractionation changing from conventional fractionation to moderate hypofractionation. This review introduces the latest research results of dose fractionation of SBRT for LAPC.
Zhang Xuyang,Wang Hao,Yang Ruijie. Dose fractionation of stereotactic body radiation therapy for locally advanced pancreatic cancer[J]. Chinese Journal of Radiation Oncology, 2016, 25(10): 1130-1134.
[1] Siegel R,Naishadham D,Jemal A.Cancer statistics,2013[J].CA Cancer J Clin,2013,63(1):11-30.DOI:10.3322/caac.21166. [2] Chang BW,Saif MW.Stereotactic body radiation therapy (SBRT) in pancreatic cancer:is it ready for prime time[J].JOP,2008,9(6):676-682. [3] Sener SF,Fremgen A,Menck HR,et al. Pancreatic cancer:a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995,using the National Cancer Database[J].J Am Coll Surg,1999,189(1):1-7.DOI:10.1016/S1072-7515(99)00075-7. [4] Koong AC,Le QT,Ho A,et al. Phase Ⅰ study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer[J].Int J Radiat Oncol Biol Phys,2004,58(4):1017-1021.DOI:10.1016/j.ijrobp.2003.11.004. [5] Koong AC,Christofferson E,Le QT,et al. Phase Ⅱ study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer[J].Int J Radiat Oncol Biol Phys,2005,63(2):320-323.DOI:10.1016/j.ijrobp.2005.07.002. [6] Schellenberg D,Goodman KA,Lee F,et al. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer[J].Int J Radiat Oncol Biol Phys,2008,72(3):678-686.DOI:10.1016/j.ijrobp.2008.01.051. [7] Schellenberg D,Kim J,Christman-Skieller C,et al. Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer[J].Int J Radiat Oncol Biol Phys,2011,81(1):181-188.DOI:10.1016/j.ijrobp.2010.05.006. [8] Hoyer M,Roed H,Sengelov L,et al. Phase-Ⅱ study on stereotactic radiotherapy of locally advanced pancreatic carcinoma[J].Radiother Oncol,2005,76(1):48-53.DOI:10.1016/j.radonc.2004.12.022. [9] Mahadevan A,Jain S,Goldstein M,et al. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer[J].Int J Radiat Oncol Biol Phys,2010,78(3):735-742.DOI:10.1016/j.ijrobp.2009.08.046. [10] Polistina F,Costantin G,Casamassima F,et al. Unresectable locally advanced pancreatic cancer:a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration[J].Ann Surg Oncol,2010,17(8):2092-2101.DOI:10.1245/s10434-010-1019-y. [11] Gurka MK,Collins SP,Slack R,et al. Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer:a pilot trial demonstrating safety[J].Radiat Oncol,2013,8:44.DOI:10.1186/1748-717X-8-44. [12] Pollom EL,Alagappan M,von ER,et al. Single-versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma:outcomes and toxicity[J].Int J Radiat Oncol Biol Phys,2014,90(4):918-925.DOI:10.1016/j.ijrobp.2014.06.066. [13] Herman JM,Chang DT,Goodman KA,et al. Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma[J].Cancer,2015,121(7):1128-1137.DOI:10.1002/cncr.29161. [14] 夏廷毅,孙庆选,于涌,等.体部γ刀治疗52例胰腺癌的疗效分析[J].中华肝胆外科杂志,2006,12(2):86-88. Xia TY,Sun QX,Yu Y,et al. Efficacy of body gamma knife in the treatment of 52 cases of pancreatic cancer[J].Chin J Hepato Surg,2006,12(2):86-88. [15] 康晓黎,王颖杰,邵银剑,等.γ射线立体定向体部放射治疗局限期胰腺癌65例[J].世界华人消化杂志,2013,21(13):1266-1272.DOI:10.11569/wcjd.v21.i13.1266. Kanbg XL,Wang YJ,Shao YJ,et al. Gamma ray stereotactic body radiotherapy for the treatment of 65 patients with localized pancreatic cancer[J].World Chin J Dig,2013,21(13):1266-1272.DOI:10.11569/wcjd.v21.i13.1266. [16] 郑伟,聂青,康静波,等.立体定向放疗联合吉西他滨治疗胰腺癌的临床观察[J].临床肿瘤学杂志,2011,16(11):995-1000. Zheng W,Niu Q,Kang JB,et al. Clinical observation of stereotactic radiotherapy combined with gemcitabine in the treatment of pancreatic cancer[J].Chin Clin Oncol,2011,16(11):995-1000. [17] 蔡晶,谢国栋,吴志军,等.立体定向适形放射治疗胰腺癌18例分析[J].中华放射肿瘤学杂志,2003,12(4):268-269. Cai J,Xie GD,Wu ZHJ,et al. Stereotactic conformal radiotherapy for pancreatic carcinoma:analysis of 18 cases[J].Chin J Radiat Oncol,2003,12(4):268-269. [18] 沈泽天,武新虎,李兵,等.射波刀治疗局部晚期胰腺癌的临床疗效分析[J].中国癌症杂志,2012,22(8):589-594.DOI:10.3969/j.issn.1007-3969.2012.08.006. Shen ZT,Wu XH,Li B,et al. Analysis of therapeutic effect of radio wave knife in the treatment of locally advanced pancreatic cancer[J].Chin Oncol,2012,22(8):589-594.DOI:10.3969/j.issn.1007-3969.2012.08.006. [19] Brunner TB,Nestle U,Grosu AL,et al. SBRT in pancreatic cancer:what is the therapeutic window?[J].Radiother Oncol,2015,114(1):109-116.DOI:10.1016/j.radonc.2014.10.015. [20] Murata R,Shibamoto Y,Sasai K,et al. Reoxygenation after single irradiation in rodent tumors of different types and sizes[J].Int J Radiat Oncol Biol Phys 1996,34(4):859–65.DOI:10.1016/0360-3016(95)02155-8. [21] Shibamoto Y,Miyakawa A,Otsuka S,et al. Radiobiology of hypofractionated stereotactic radiotherapy:what are the optimal fractionation schedules?[J].J Radiat Res,2016,DOI:10.1093/jrr/rrw015. [22] Tozzi A,Comito T,Alongi F,et al. SBRT in unresectable advanced pancreatic cancer:preliminary results of a mono-institutional experience[J].Radiat Oncol,2013,21;8:148.DOI:10.1186/1748-717X-8-148. [23] Comito T,Cozzi L,Clerici E,et al. Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic Adenocarcinoma? Results of a phase 2 study[J].Technol Cancer Res Treat.2016 June,DOI:10.1177/1533034616650778. [24] Kim MS,Kim W,Park IH,et al. Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery[J].Radiat Oncol J,2015,33(4):265-275.DOI:10.3857/roj.2015.33.4.265. [25] Brown JM,Carlson DJ,Brenner DJ.The tumor radiobiology of SRS and SBRT:are more than the 5 R’s involved?[J].Int J Radiat Oncol Biol Phys.2014,88(2):254-262.DOI:10.1016/j.ijrobp.2013.07.022. [26] Song CW,Kin MS,Cho LC,et al. Radiobiological basis of SBRT and SRS[J].Int J Clin Oncol,2014 19:570-578.DOI 10.1007/s10147-014-0717-z. [27] Brenner DJ.The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction[J].Semin Radiat Oncol,2008;18:234-9.DOI:10.1016/j.semradonc.2008.04.004. [28] Park C,Papiez L,Zhang SQ,et al. Universal survival curve and single fraction equivalent dose:useful tools in understanding potency of ablative radiotherapy[J].Int J Radiat Oncol Biol Phys,2008,70(3):847-852.DOI:10.1016/j.ijrobp.2007.10.059. [29] Garcia LM, Leblanc J, Wilkins D, et al. Fitting the linear-quadratic model to detailed data sets for different dose ranges[J].Phys Med Biol,2006,51,2813-2823.DOI:10.1088/0031-9155/51/11/009.
2016, Vol. 25 
